Riskpilot← Back to searchSign inGet full accessDiaSystem Scandinavia AB
ABActiveOrg 5568137441Datorgatan 3 1trManufacture of irradiation, electromedical and electrotherapeutic equipment · NACE 2660Est. 20102 employees
Revenue 2024
SEK 11,9M
-3% vs 2023
EBITDA margin
-36.7%
+1% vs 2023
Equity ratio
7.5%
Financial strength
Net profit 2024
SEK -4,6M
-1% vs 2023
| Revenue | SEK 11,9M | -3% |
| EBITDA | SEK -4,3M | +1% |
| Net profit | SEK -4,6M | -1% |
| Total assets | SEK 7,9M | -31% |
| Equity | SEK 593K | -89% |
| Employees | 2 | — |
Legal name
DiaSystem Scandinavia AB
Org number
5568137441
Legal form
Aktiebolag
NACE code
2660 · Manufacture of irradiation, electromedical and electrotherapeutic equipment
Founded
5 juli 2010
Share capital
SEK 50 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska bedriva handel med diagnostika och analys- instrument samt tillverkning av diagnostika, samt därmed förenlig verksamhet.
Address
Datorgatan 3 1tr
Phone
+4636126220
Email
werner@diasystem.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 11 423 | 16 010 | 15 871 | 12 203 | 11 856 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 363 | 609 | 213 | −4 390 | −4 347 |
| Depreciation & amort. | −0 | −105 | −105 | −105 | −105 |
| EBIT | 363 | 504 | 108 | −4 495 | −4 452 |
| Net financials | −93 | −89 | −162 | −108 | −368 |
| Profit before tax | 270 | 363 | −54 | −4 576 | −4 609 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 270 | 363 | −54 | −4 576 | −4 609 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 8 228 | 15 787 | 16 350 | 11 456 | 7 917 |
| Equity | 2 450 | 2 812 | 2 758 | 5 202 | 593 |
| Long-term debt | 4 352 | 6 456 | 6 964 | 1 125 | 872 |
| Short-term debt | 1 426 | 6 467 | 6 576 | 5 103 | 6 452 |
| Total debt | 5 778 | 12 923 | 13 540 | 6 228 | 7 324 |
EBITDA margin
-36.7%
This company
15.8%
Market median
-332% vs market
20202024
Equity ratio
7.5%
This company
38.2%
Market median
-80% vs market
20202024
Return on equity
-777.2%
This company
18.4%
Market median
-4324% vs market
20202024
Net profit margin
-38.9%
This company
8.1%
Market median
-580% vs market
20202024
Asset turnover
1.50×
This company
1.12×
Market median
+34% vs market
20202024
Debt / equity
12.35×
This company
0.62×
Market median
-1892% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PA | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2021 | |
| Deputy Board Member | 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Biomed PWR AB
DiaSystem Scandinavia AB Board members of DiaSystem Scandinavia AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Pär Anders Tomas Claesson | Audit | 0 companies |
| Max Peter Erwin Werner Rademacher | Board of Directors | 0 companies |
| Piroska Rademacher | Deputy Board Member | 0 companies |